The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol
Clinical trial NCT00438789 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT00438789
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.